Exhibtion/Conference
-
21
Jun
Glad To Visiting Hungarian Distributor In BudapestIt was so pleasure of visiting our Hungarian distributor in Budapest. We were excited to meet with our partner and discussed the future of our cooperation. We were delighted to hear that business h...
Read More -
20
Jun
NeuroSafe Appeared At LINNC Paris 2023 To Enhance Their Influence in Overseas...In June, LINNC PARIS 2023 will be held in Paris, France. As a neurointerventional medical device company, NeuroSafe participated in the exhibition and brought excellent innovative products and rich...
Read More -
20
Jun
Good News! Our Partner Is About To Get The Product Registration Certificate i...Good news! Congratulations to our India partner Globe Bio Medicals who is about to get the product registration certificate of the Lava Liquid Embolic System,Dredger Revascularization Device and Gl...
Read More -
16
Jun
A Wonderful Meeting On LINNC Paris 2023NeuroSafe would like to say thank you to LINNC Paris 2023 - what an incredible few days! Those of us who attended had an amazing time connecting and learning together. We also would like to thank a...
Read More -
05
Jun
NeuroSafe Is Attending LINNC 2023 in ParisNeuroSafe will be attending LINNC 2023 in Paris, France! Please join us at Booth #2 and discover our latest progress in neurointervention products! NeuoSafe Medical, a high technoloy company in the...
Read More -
17
May
Clinical Center's Summary for LAVA Liquid Embolic SystemThe 75 enrolled cases (38 cases in the test group and 37 cases in the control group) were successfully embolized and withdrawn smoothly, and the embolization success rate was 100%. Director Haowen ...
Read More -
26
Apr
NeuroSafe Is The First Company To Get CE Ceritifate in ChinaVBDATA is a leading medical and health industry research institution and media platform in China. On 17 April. 2023, Mr. Qiu, General Manger of NeuroSafe, was interviewed by VBDATA and introduced L...
Read More -
26
Apr
Report Of The Clinical Trial Progress Of LAVA Liquid Embolic SystemLAVA Liquid Embolic System have been made the clinical trials from Jan 2022 in Chinese hospitals. Till now, the 75 enrolled subjects (38 in the experimental group and 37 in the control group) were ...
Read More -
17
Apr
NeuroSafe's LAVA Liquid Embolic System: Obtained the First Certificate for Ne...Stroke is the most common clinical cerebrovascular disease with high disability and mortality rates. The treatment of stroke has been a major problem in neurosurgery for many years. In recent years...
Read More -
04
Apr
NeurSafe’s Products Was Published in The Turkey's Healthcare MagazineWe are excited and grateful to our local distributor in Turkey to promote NeuroSafe’s products with Lava TM Liquid Embolic System, Dredger TM Revascularization Device and Glutton TM Aspiration Cath...
Read More -
31
Mar
NeuroSafe’s Local Distributor Attended 3rd Oncology Meeting in TurkeyThe third meeting of "Interventional Oncology: Multidisciplinary Treatment Approach" was held at Divan Ankara Hotel in Turkey on 13-14 January 2023. This meeting was supported by Turkish leading co...
Read More -
21
Mar
NeuroSafe Will Attend LINNC Paris 2023The LINNC conference is one of the most important neurointerventional conferences in the world. Every year, it attracts many clinical interventional neurologists and neurosurgeons from all over the...
Read More




